2m 2m 2m 2m 2m 2m 2m
KARDIGAN (KARD)
NASDAQ
$12.81+$0.005 (+0.04%)
Price as of Oct 23, 2026 7:56 PM EDT- $1.2BMarket Cap
- N/A1-Year Change
- BiotechnologyIndustry
KARDIGAN (KARD)
$12.81+$0.005 (+0.04%)
Top Holders
Institutional
Mutual Funds
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
SCHF (GPE), LLC | 18.94% | 16.9M | +16.9M (+100.00%) | Jun 30, 2026 |
FMR LLC | 9.97% | 8.9M | +8.9M (+100.00%) | Jun 30, 2026 |
PERCEPTIVE ADVISORS LLC | 9.18% | 8.2M | +8.2M (+100.00%) | Jun 30, 2026 |
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 4.71% | 4.2M | +4.2M (+100.00%) | Jun 30, 2026 |
CAPITAL RESEARCH GLOBAL INVESTORS | 4.03% | 3.6M | +3.6M (+100.00%) | Jun 30, 2026 |
JPMORGAN CHASE & CO | 2.00% | 1.8M | +1.8M (+100.00%) | Jun 30, 2026 |
ALLIANCEBERNSTEIN L.P. | 1.72% | 1.5M | +1.5M (+100.00%) | Jun 30, 2026 |
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
SMALLCAP WORLD FUND INC | 3.92% | 3.5M | +3.5M (+100.00%) | Jun 30, 2026 |
FIDELITY CONTRAFUND | 1.73% | 1.5M | +1.5M (+100.00%) | Jun 30, 2026 |
JPMORGAN TRUST II | 0.92% | 823,598 | +823,598 (+100.00%) | Jun 30, 2026 |
AB CAP FUND, INC. | 0.83% | 741,883 | +741,883 (+100.00%) | Jun 30, 2026 |
T. Rowe Price Small-Cap Stock Fund, Inc. | 0.83% | 737,233 | +737,233 (+100.00%) | Jun 30, 2026 |
T. Rowe Price Small-Cap Value Fund, Inc. | 0.71% | 633,307 | +633,307 (+100.00%) | Jun 30, 2026 |
FIDELITY SECURITIES FUND | 0.54% | 483,600 | +483,600 (+100.00%) | Jul 31, 2026 |
Current Ownership Distribution
- Institutions58.0M (64.88%)
- Other19.3M (21.61%)
- Mutual Funds12.0M (13.45%)
- Insiders48,368 (0.05%)
Insider Transactions
- 0.05% (48,368)Current InsiderOwnership (%, shares)
- 1Number of InsiderBuying (last 12 months)
- $220.7MAmount of InsiderBuying (last 12 months)
- 0Number of InsiderSelling (last 12 months)
- $0.00Amount of InsiderSelling (last 12 months)
Insider Name & Title | Type | Date
| Transaction Value | Shares | Share Price | Shares After Transactions |
|---|---|---|---|---|---|---|
ARCH Venture Partners XIII, LLC | Buy | Jun 22, 2026 | $20.0M | 1.3M | $16.00 | 15.0M |
GIANAKAKOS ANASTASIOS President & CEO | Conversion | Jun 17, 2026 | $0.00 | 18,020 | $0.00 | 0 |
PERCEPTIVE ADVISORS LLC | Award | Jun 17, 2026 | $0.00 | 20,706 | $0.00 | 20,706 |
GIANAKAKOS ANASTASIOS President & CEO | Conversion | Jun 17, 2026 | $0.00 | 25,742 | $0.00 | 0 |
Edelberg Jay Chief Medical Officer | Conversion | Jun 17, 2026 | $0.00 | 61,268 | $0.00 | 0 |
GIANAKAKOS ANASTASIOS President & CEO | Conversion | Jun 17, 2026 | $0.00 | 313,092 | $0.00 | 0 |
Edelberg Jay Chief Medical Officer | Conversion | Jun 17, 2026 | $0.00 | 97,587 | $0.00 | 135,543 |
GIANAKAKOS ANASTASIOS President & CEO | Conversion | Jun 17, 2026 | $0.00 | 28,702 | $0.00 | 5.7M |
Edelberg Jay Chief Medical Officer | Award | Jun 17, 2026 | $0.00 | 47,784 | $0.00 | 183,327 |
GIANAKAKOS ANASTASIOS President & CEO | Conversion | Jun 17, 2026 | $0.00 | 41,001 | $0.00 | 2.4M |
GIANAKAKOS ANASTASIOS President & CEO | Conversion | Jun 17, 2026 | $0.00 | 498,692 | $0.00 | 498,692 |